A
Written by
Part of the AWPCAB movement advancing HIV prevention choice and accountability across Eastern and Southern Africa.
Rita Monchari Nyaberi
Keep reading
More from the movement
FDA Approval of Bixlenvo: AWPCAB Demands Focus on African Girls and Women
AWPCAB welcomes the U.S. FDA approval of Bixlenvo (bictegravir and lenacapavir) and calls for…
Read storyThey Walked In as Learners. They Left Ready to Lead.
“You’re not going to be the same person when you leave here.” It was…
Read storyLenacapavir in South Africa: A Milestone Worth Celebrating, and a Reminder of the Work Ahead
SOUTH AFRICA – South Africa’s launch of Lenacapavir marks an important moment in the…
Read story